Home > Boards > US Listed > Biotechs > MediciNova, Inc. (MNOV)

Good, I'm glad you have enough patience for

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
someconcerns Member Profile
 
Followed By 31
Posts 2,560
Boards Moderated 1
Alias Born 04/01/09
160x600 placeholder
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan GlobeNewswire Inc. - 10/23/2019 6:00:05 AM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary F... GlobeNewswire Inc. - 10/7/2019 7:00:00 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in ... GlobeNewswire Inc. - 9/30/2019 7:00:00 PM
MediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New York GlobeNewswire Inc. - 9/11/2019 7:00:00 PM
MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York GlobeNewswire Inc. - 8/29/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 5:03:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/23/2019 5:02:32 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/23/2019 6:00:54 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/9/2019 5:03:28 PM
MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in J... GlobeNewswire Inc. - 7/30/2019 7:00:00 PM
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND... GlobeNewswire Inc. - 7/29/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 6:05:48 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/25/2019 4:17:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/25/2019 11:27:05 AM
MediciNova Appoints Kazuko Matsuda to its Board of Directors GlobeNewswire Inc. - 7/24/2019 11:00:00 PM
MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS GlobeNewswire Inc. - 7/11/2019 7:00:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/21/2019 12:13:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:07:04 PM
MediciNova to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:15:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:05:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:03:53 PM
MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS GlobeNewswire Inc. - 6/5/2019 7:00:00 PM
MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire Inc. - 5/15/2019 7:00:00 PM
someconcerns   Friday, 09/11/15 01:33:14 PM
Re: Ebuilder post# 373
Post # of 392 
Good, I'm glad you have enough patience for the MNOV volcano to build up steam. It will blow when it's ready.

All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist